Login to Your Account

Flips on light switch with $13M

Spirulina platform Lumen large as firm bags series A, therapies and more ahead

By Randy Osborne
Staff Writer

Monday, December 4, 2017

Lumen Bioscience Inc. plans to use its $11.2 million in series A money – supplemented by $1.8 million in the form of a grant from the U.S. Department of Energy – to explore the use of spirulina in making therapeutic products, CEO and co-founder Brian Finrow told BioWorld Insight.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription